GLP 1 Inhibitors and Weightloss Ashley Asbill [citrus diet pills]

GLP 1 Inhibitors and Weightloss Ashley Asbill [citrus diet pills]

| 1h 28m 28s | Video has closed captioning.

GLP-1 receptor agonists and SGLT-2 inhibitors represent significant progress in addressing the health issues that go with obesity. Their ability to improve glucose control, aid in weight management, and reduce cardiovascular risks holds promise for alleviating the societal and economic impact of obesity-related health challenges. Integrating these innovative treatments into personalized care strategies can help ease the burden of obesity-related health issues we face.